Immediate and 12 months follow up of function and lead integrity after cranial MRI in 356 patients with conventional cardiac pacemakers

J Cardiovasc Magn Reson. 2014 Jun 5;16(1):39. doi: 10.1186/1532-429X-16-39.

Abstract

Background: Conventional cardiac pacemakers are still often regarded as a contraindication to magnetic resonance imaging (MRI). We conducted this study to support the hypothesis that it is safe to scan patients with cardiac pacemakers in a 1.5 Tesla MRI, if close supervision and monitoring as well as adequate pre- and postscan programming is provided.

Methods: We followed up 356 patients (age 61.3 ± 9.1 yrs., 229 men) with single (n = 132) or dual chamber (n = 224) cardiac pacemakers and urgent indication for a cranial MRI for 12 months. The scans were performed at 1.5T. During the scan patients were monitored with a 3-lead ECG and pulse oximetry. Prior to the scan pacemakers were programmed according to our own protocol.

Results: All 356 scans were completed without complications. No arrhythmias were induced, programmed parameters remained unchanged. No pacemaker dysfunction was identified. Follow-up examinations were performed immediately, 2 weeks, 2, 6, and 12 months after the scan. There was no significant change of pacing capture threshold (ventricular 0.9 ± 0.4 [email protected] ms, atrial 0.9 ± 0.3 [email protected] ms) immediately (ventricular 1.0 ± 0.3 [email protected] ms, atrial 0.9 ± 0.4 [email protected] ms) or at 12 months follow-up examinations (ventricular 0.9 ± 0.2 [email protected] ms, atrial 0.9 ± 0.3 [email protected] ms). There was no significant change in sensing threshold (8.0 ± 4.0 mV vs. 8.1 ± 4.2 mV ventricular lead, 2.0 ± 0.9 mV vs. 2.1 ± 1.0 mV atrial lead) or lead impedance (ventricular 584 ± 179 Ω vs. 578 ± 188 Ω, atrial 534 ± 176 Ω vs. 532 ± 169 Ω) after 12 months.

Conclusions: This supports the evidence that patients with conventional pacemakers can safely undergo cranial MRI in a 1.5T system with suitable preparation, supervision and precautions. Long term follow-up did not reveal significant changes in pacing capture nor sensing threshold.

MeSH terms

  • Aged
  • Arrhythmias, Cardiac / diagnosis
  • Arrhythmias, Cardiac / physiopathology
  • Arrhythmias, Cardiac / therapy*
  • Brain Diseases / diagnosis*
  • Brain Diseases / pathology
  • Cardiac Pacing, Artificial*
  • Contraindications
  • Electrocardiography
  • Equipment Design
  • Equipment Failure
  • Female
  • Humans
  • Magnetic Resonance Imaging*
  • Male
  • Middle Aged
  • Oximetry
  • Pacemaker, Artificial*
  • Patient Safety
  • Predictive Value of Tests
  • Risk Assessment
  • Risk Factors
  • Time Factors